-
Je něco špatně v tomto záznamu ?
The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis
M. Fujáková, T. Páleníček, M. Brunovský, I. Gorman, F. Tylš, A. Kubešová, D. Řípová, V. Krajča, J. Horáček,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
NT13897
MZ0
CEP - Centrální evidence projektů
NT13403
MZ0
CEP - Centrální evidence projektů
- MeSH
- aminokyseliny farmakologie terapeutické užití MeSH
- antipsychotika farmakologie terapeutické užití MeSH
- bicyklické sloučeniny heterocyklické farmakologie terapeutické užití MeSH
- elektroencefalografie účinky léků metody MeSH
- ketamin toxicita MeSH
- krysa rodu rattus MeSH
- modely nemocí na zvířatech * MeSH
- potkani Wistar MeSH
- psychotické poruchy farmakoterapie patofyziologie MeSH
- receptory metabotropního glutamátu agonisté MeSH
- výsledek terapie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
In the present study we investigated the potential antipsychotic effects of the mGlu2/3 agonist LY379268 on changes in EEG power spectra and coherence in the ketamine model of psychosis. In order to use behaviorally active drug doses, experiments detecting changes in locomotor activity and sensorimotor gating were also conducted. In EEG experiments, adult male Wistar rats were injected with ketamine 30 mg/kg i.p. and LY379268 3 mg/kg i.p. Cortical EEG was recorded from twelve (2 × 6) electrodes placed homolaterally on each hemisphere. To avoid interference with the behavioral hyperactivity of ketamine challenge, the behavioral activity of animals was simultaneously registered at the time of recording. Subsequent power spectral and coherence analyses were assessed in epochs corresponding to behavioral inactivity. Analysis of segments with behavioral activity compared to inactivity was also performed. The effects of LY379268 3 mg/kg i.p. on the deficits in sensorimotor processing and on hyperlocomotion induced by ketamine were evaluated in the test of prepulse inhibition of acoustic startle reaction (PPI ASR) and in the open field. LY379268 reversed the ketamine-induced hyperlocomotion but had no effect on ketamine-induced PPI deficits. In EEG epochs corresponding to behavioral inactivity ketamine decreased the power in the delta band, induced a power increase in the high frequency bands and globally decreased EEG coherence. Pretreatment with the LY379268 completely reversed the ketamine-induced power increase in high frequency bands and had a partial effect on EEG coherence. LY379268 alone induced a decrease of beta, high beta and low-gamma power, and an increase in coherence in high frequency bands. Additional analysis revealed that behavioral activity increases power as well as coherence in most frequency bands. In conclusion, agonism of mGlu2/3 receptors was effective in reversing most of the changes induced by ketamine, however due to the lack of effectiveness on PPI deficits its potential antipsychotic properties remain disputable.
3rd Faculty of Medicine Charles University Prague Ruská 87 100 00 Prague 10 Czech Republic
Prague Psychiatric Center Ústavní 91 18103 Prague 8 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15014473
- 003
- CZ-PrNML
- 005
- 20181026090803.0
- 007
- ta
- 008
- 150420s2014 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.pbb.2014.03.001 $2 doi
- 035 __
- $a (PubMed)24631484
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Fujáková, Michaela $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic; 3rd Faculty of Medicine, Charles University in Prague, Ruská 87, 100 00 Prague 10, Czech Republic. Electronic address: fujakova@pcp.lf3.cuni.cz. $7 _AN027808
- 245 14
- $a The effect of ((-)-2-oxa-4-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY379268), an mGlu2/3 receptor agonist, on EEG power spectra and coherence in ketamine model of psychosis / $c M. Fujáková, T. Páleníček, M. Brunovský, I. Gorman, F. Tylš, A. Kubešová, D. Řípová, V. Krajča, J. Horáček,
- 520 9_
- $a In the present study we investigated the potential antipsychotic effects of the mGlu2/3 agonist LY379268 on changes in EEG power spectra and coherence in the ketamine model of psychosis. In order to use behaviorally active drug doses, experiments detecting changes in locomotor activity and sensorimotor gating were also conducted. In EEG experiments, adult male Wistar rats were injected with ketamine 30 mg/kg i.p. and LY379268 3 mg/kg i.p. Cortical EEG was recorded from twelve (2 × 6) electrodes placed homolaterally on each hemisphere. To avoid interference with the behavioral hyperactivity of ketamine challenge, the behavioral activity of animals was simultaneously registered at the time of recording. Subsequent power spectral and coherence analyses were assessed in epochs corresponding to behavioral inactivity. Analysis of segments with behavioral activity compared to inactivity was also performed. The effects of LY379268 3 mg/kg i.p. on the deficits in sensorimotor processing and on hyperlocomotion induced by ketamine were evaluated in the test of prepulse inhibition of acoustic startle reaction (PPI ASR) and in the open field. LY379268 reversed the ketamine-induced hyperlocomotion but had no effect on ketamine-induced PPI deficits. In EEG epochs corresponding to behavioral inactivity ketamine decreased the power in the delta band, induced a power increase in the high frequency bands and globally decreased EEG coherence. Pretreatment with the LY379268 completely reversed the ketamine-induced power increase in high frequency bands and had a partial effect on EEG coherence. LY379268 alone induced a decrease of beta, high beta and low-gamma power, and an increase in coherence in high frequency bands. Additional analysis revealed that behavioral activity increases power as well as coherence in most frequency bands. In conclusion, agonism of mGlu2/3 receptors was effective in reversing most of the changes induced by ketamine, however due to the lack of effectiveness on PPI deficits its potential antipsychotic properties remain disputable.
- 650 _2
- $a aminokyseliny $x farmakologie $x terapeutické užití $7 D000596
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antipsychotika $x farmakologie $x terapeutické užití $7 D014150
- 650 _2
- $a bicyklické sloučeniny heterocyklické $x farmakologie $x terapeutické užití $7 D019086
- 650 12
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a elektroencefalografie $x účinky léků $x metody $7 D004569
- 650 _2
- $a ketamin $x toxicita $7 D007649
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a psychotické poruchy $x farmakoterapie $x patofyziologie $7 D011618
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a receptory metabotropního glutamátu $x agonisté $7 D018094
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Páleníček, Tomáš, $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic. $d 1976- $7 mzk2004257555
- 700 1_
- $a Brunovský, Martin, $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic. $d 1975- $7 xx0070660
- 700 1_
- $a Gorman, Ingmar $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic. $7 _AN045561
- 700 1_
- $a Tylš, Filip, $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic; 3rd Faculty of Medicine, Charles University in Prague, Ruská 87, 100 00 Prague 10, Czech Republic. $d 1985- $7 xx0218168
- 700 1_
- $a Kubešová, Anna $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic; 3rd Faculty of Medicine, Charles University in Prague, Ruská 87, 100 00 Prague 10, Czech Republic. $7 _AN064719
- 700 1_
- $a Řípová, Daniela, $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic. $d 1953- $7 xx0091955
- 700 1_
- $a Krajča, Vladimír $u Czech Technical University in Prague, Faculty of Biomedical Engineering, Nám. Sítná 3105, 272 01 Kladno, Czech Republic. $7 _AN096094
- 700 1_
- $a Horáček, Jiří, $u Prague Psychiatric Center, Ústavní 91, 18103, Prague 8, Czech Republic; 3rd Faculty of Medicine, Charles University in Prague, Ruská 87, 100 00 Prague 10, Czech Republic. $d 1966- $7 jo2002152353
- 773 0_
- $w MED00003794 $t Pharmacology, biochemistry, and behavior $x 1873-5177 $g Roč. 122, č. - (2014), s. 212-221
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/24631484 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20150420 $b ABA008
- 991 __
- $a 20181026091314 $b ABA008
- 999 __
- $a ok $b bmc $g 1072054 $s 897351
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 122 $c - $d 212-221 $i 1873-5177 $m Pharmacology, biochemistry and behavior $n Pharmacol Biochem Behav $x MED00003794
- GRA __
- $a NT13897 $p MZ0
- GRA __
- $a NT13403 $p MZ0
- LZP __
- $a Pubmed-20150420